Skip to main content
Clinical Trials/JPRN-UMIN000048340
JPRN-UMIN000048340
Not yet recruiting
未知

Assessment of accuracy of AI (Artificial Intelligence) algorithm for early diagnosis of joint disorders in hemophilia patients using ultrasound imaging. - Hemophilia US AI algorithm study

Chugai Pharmaceutical Co., Ltd.0 sites5,500 target enrollmentJuly 12, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Chugai Pharmaceutical Co., Ltd.
Enrollment
5500
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 12, 2022
End Date
October 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients expressing refusal to allow the use of images and existing data in this study. Patients with diseases other than congenital hemophilia A and congenital hemophilia B with joint involvement.

Outcomes

Primary Outcomes

Not specified

Similar Trials